Mark Blazejewski is a BioPharma commercial executive with over 25 years of experience in market access, patient support, and marketing. Currently serving as the Head of Market Access Strategy and Marketing at Genmab, Mark focuses on value proposition strategy and new product commercial planning and launch. Previously, Mark held various leadership roles at Novartis, including Executive Director for Patient Support in the Chronic Myeloid Leukemia franchise, where significant achievements included developing innovative patient support programs and optimizing strategies for products like ENTRESTO and LEQVIO. Mark's work emphasizes enhancing patient access and affordability while ensuring successful product commercialization. Mark earned a Bachelor of Arts in Sciences & Humanities from Fordham University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices